Page 693 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 693
enlargement. Recurrent lesions are more common with Sexually Transmitted Diseases 679
HSV-1 than with HSV-2 infection, and in general are less
painful and less extensive than primary lesions. Clark PE: Bladder cancer. Curr Opin Oncol 19:241, 2007. [Reviews the
• On histologic examination the vesicles of HSV infection diagnosis and management of both more superficial and advanced bladder
contain necrotic cells and fused multinucleate giant cells cancer.]
with intranuclear inclusions (Cowdry type A) that stain
with antibodies to the virus. Donovan B: Sexually transmitted infections other than HIV. Lancet
• Neonatal herpes can be life-threatening and occurs in 363:545, 2004. [A clinical review of STDs.]
children born to mothers with genital herpes. Affected
infants have generalized herpes, often associated with Epstein JI: An update of the Gleason grading system. J Urol 183:433,
encephalitis and consequent high mortality. 2010.
• HPV causes many proliferative lesions of the genital
mucosa, including condyloma acuminatum, precancerous Gori S, Porrozzi S, Roila F, et al: Germ cell tumours of the testis. Crit
lesions, and invasive cancers. Rev Oncol Hematol 53:141, 2005. [An informative review of the predis-
posing factors, clinical features, and treatment of testicular neoplasms.]
BIBLIOGRAPHY
Hsing AW, Chokkalingam AP: Prostate cancer epidemiology. Front
Bahrami A, Ro JY, Ayala AG: An overview of testicular germ cell Biosci 11:1388, 2006.
tumors. Arch Pathol Lab Med 131:1267, 2007.
Loeb SA, Catalona WJ: Prostate-specific antigen in clinical practice.
Bleeker MC, Heideman DA, Snijders PJ, et al: Penile cancer: epidemi- Cancer Lett 249:30, 2007. [An excellent summary of clinical use of PSA.]
ology, pathogenesis, and prevention. World J Urol 27:141, 2009. [A
systematic review of the literature evaluating penile carcinogenesis, risk Le BV, Schaeffer AJ: Genitourinary pain syndromes, prostatitis and
factors, and molecular mechanisms involved.] lower urinary tract symptoms. Urol Clin North Am 36:527, 2009. [A
recent review of the etiology, diagnosis, symptoms, and treatment of pros-
Bushman W: Etiology, epidemiology, and natural history of benign tatitis and interstitial cystitis along with pelvic pain syndromes.]
prostatic hyperplasia. Urol Clin N Am 36:403, 2009.
Lee PK, Wilkins KB: Condyloma and other infections including
Centers for Disease Control and Prevention, Workowski KA, Berman human immunodeficiency virus. Surg Clin North Am 90:99, 2010.
SM: Sexually transmitted diseases treatment guidelines, 2006.
MMWR Recomm Rep 55:1, 2006. [An excellent updated review along Makorov DV, Loeb S, Getzenberg RH, Partin AW: Biomarkers for
with treatment recommendations.] prostate cancer. Annu Rev Med 60:139, 2009. [A review covering PSA
and possible new prostate cancer biomarkers that are under evaluation.]
Mitra AP, Cole RJ: Molecular pathogenesis and diagnostics of bladder
cancer. Annu Rev Pathol 4:251, 2008.
Nelson WG, De Marzo AM, Yegnasubramanian S: Epigenetic altera-
tions in human prostate cancers. Endocrinology 150:3991, 2009.
Patel AK, Chapple CR: Medical management of lower urinary tract
symptoms in men: current treatment and future approaches. Nat
Clin Pract Urol 5:211, 2008. [This article also clarifies the terminology
used to evaluate men with lower urinary tract symptoms.]
Rapley EA, Nathanson KL: Predisposition alleles for testicular germ
cell tumour. Curr Opin Genes Dev 20:225, 2010. [An update on inher-
ited risk factors in germ cell tumors.]
Shand RL, Gelmann EP: Molecular biology of prostate-cancer patho-
genesis. Curr Opin Urol 16:123, 2006.
Sulak PJ: Sexually transmitted diseases. Semin Reprod Med 21:399,
2003. [An exhaustive review of STDs.]
